AbCellera
continued progress and differentiation for cell engager platform improve the safety profile of cell expand the accessible target space for cell in solid tumors have tremendous potential treatment cancer conditions but are technically challenging to design engineer combines unique discovery capabilities engineering a panel hundreds diverse binding antibodies to potentially by creating antibodies that achieve potent tumor killing with reduced release which can help address dose limiting toxicity by enabling discovery antibodies that are highly specific to peptide complexes | AbCellera
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
10 of 14
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Results
November 2023
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io